Have a feature idea you'd love to see implemented?
Let us know!
INKT MiNK Therapeutics Inc
Price (delayed)
$0.6901
Market cap
$27.29M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.38
Enterprise value
$25.58M
Highlights
INKT's EPS is up by 48% year-on-year and by 21% since the previous quarter
MiNK Therapeutics's net income has increased by 44% YoY and by 19% QoQ
MiNK Therapeutics's quick ratio has increased by 39% YoY but it has decreased by 7% from the previous quarter
MiNK Therapeutics's equity has decreased by 29% YoY and by 6% from the previous quarter
The debt has grown by 4.7% from the previous quarter
Key stats
What are the main financial stats of INKT
Market
Valuations
Earnings
Shares outstanding
39.55M
Market cap
$27.29M
Enterprise value
$25.58M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$13.78M
EBITDA
-$13.57M
Free cash flow
-$10.86M
Per share
Balance sheet
Liquidity
EPS
-$0.38
Free cash flow per share
-$0.27
Book value per share
-$0.44
Revenue per share
$0
TBVPS
$0.19
Total assets
$7.37M
Total liabilities
$24.93M
Debt
$4.61M
Equity
-$17.55M
Working capital
-$823,773
Debt to equity
-0.26
Current ratio
0.89
Quick ratio
0.86
Net debt/EBITDA
0.13
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-189.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INKT stock price
How has the MiNK Therapeutics stock price performed over time
Intraday
-2.1%
1 week
-7.99%
1 month
-0.13%
1 year
-33.64%
YTD
-35.5%
QTD
-7.99%
Financial performance
How have MiNK Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.29M
Net income
-$13.78M
Gross margin
N/A
Net margin
N/A
INKT's operating income is up by 44% YoY and by 19% QoQ
MiNK Therapeutics's net income has increased by 44% YoY and by 19% QoQ
Growth
What is MiNK Therapeutics's growth rate over time
Valuation
What is MiNK Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
INKT's EPS is up by 48% year-on-year and by 21% since the previous quarter
MiNK Therapeutics's equity has decreased by 29% YoY and by 6% from the previous quarter
Efficiency
How efficient is MiNK Therapeutics business performance
MiNK Therapeutics's ROA has increased by 19% from the previous quarter but it has decreased by 10% YoY
Dividends
What is INKT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INKT.
Financial health
How did MiNK Therapeutics financials performed over time
The total assets is 70% lower than the total liabilities
INKT's current ratio is up by 44% year-on-year but it is down by 4.3% since the previous quarter
MiNK Therapeutics's quick ratio has increased by 39% YoY but it has decreased by 7% from the previous quarter
The debt is 126% more than the equity
MiNK Therapeutics's equity has decreased by 29% YoY and by 6% from the previous quarter
The debt has grown by 4.7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.